420 with CNW – Study Finds Legalized Recreational Cannabis a Danger to Alcohol, Not Tobacco

The recent wave of adult-use marijuana legalization across the U.S. has the potential of generating $22 billion in annual sales, but not everyone is thrilled about this development. New research that will soon be published in the Marketing Science journal shows that the alcohol industry is likely to take a hit once marijuana is legalized.

The research was done by Pengyuan, an assistant professor at the Terry College of Business (University of Georgia). He worked with Guiyang Xiong from Syracuse University.

The duo analyzed online search data taken from one of the leading web portals based in the U.S. In total, they crunched the numbers on 120 million ad impressions and 28 million anonymous searches done using this portal. The data in question covered the period January 2014 to April 2017.

The research revealed that the number of online searches done for alcohol reduced by almost 11 percent while the searches for tobacco and its products saw an increase of 8 percent.

The tobacco and alcohol industries are worth a total of $300 billion in the U.S. alone. While these two industries have been vehemently opposed to the legalization of cannabis, this research shows that the tobacco industry would be well advised to revisit their opposition to legal marijuana since opposing the advance of cannabis isn’t in their best interest.

However, the alcohol industry is justified (from an existential point of view) to oppose the onward march of legal marijuana across the country since a law legalizing marijuana at the federal level would see a major decline in the sales of alcohol. The industry therefore has to think fast and come up with ways to retain their customers if they want to retain as much of their market share as possible.

Interestingly, while this research revealed that the legalization of adult-use marijuana in a state causes 17 percent more adults to conduct online searches on marijuana, the number of people who are less than 19 show a reduced interest in marijuana (or at least they perform fewer online searches on the substance).

This again serves to dispel another perception that the legalization of recreational cannabis causes a spike in the interest shown in the substance by minors. Policymakers may therefore need to revisit their positions if they based any decisions they made upon a presumption that there will be an uptick in the number of people who show interest in the drug yet they aren’t of age.

These findings seem to make sense because pollsters have pointed out severally that many adults would opt for recreational marijuana rather than alcohol since pot doesn’t come with hangovers, weight gain and the other effects of consuming alcohol on a regular basis.

It would be interesting to know what industry players like Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)  are planning to do in response to the likely spike in the opposition of the alcohol industry once the findings of this research are released and the fears of the alcohol industry are confirmed.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Congress Considers Stopping Denying Veterans Home Loans Due to Cannabis Industry Work

The House Rules Committee of Congress is going to consider an amendment this week that seeks to stop the Department of Veterans Affairs (VA) from denying the home loan requests of veterans who derive all or part of their income from work in state-legal marijuana industries.

Rep. Katherine Clark (D-MA) filed the measure that, if passed, will be attached to the National Defense Authorization Act.

Previously, it wasn’t known to the public and lawmakers that the VA had a policy of denying any home loan application of a veteran who worked in a marijuana company in a state where the industry is legal. However, one constituent of the mover of this amendment drew the attention of the lawmaker to this issue early this year and Clark immediately started working to correct this practice.

In May, Rep. Clark spearheaded a move to get lawmakers to sign a letter addressed to the VA on this unfair policy. In their letter, they noted that a significant number of veterans work in the marijuana industry and more will join them as more states legalize the industry.

The bipartisan group of legislators urged the VA to acknowledge and clarify that veterans will not be denied their benefits just because of the industry in which they work.

At about the same time, the House Appropriations Committee wrote a report highlighting the lack of clarity on the rules of the VA on home loans for veterans who work in the state-legal cannabis industry. The panel went ahead to impose a 180-day deadline within which the department should clarify what its official position on this issue is.

Clark’s amendment has language to the effect that the VA will not use a veteran’s employment in a state-legal cannabis business as a basis to determine the suitability of that person for a housing loan.

Last month, another Congressional committee approved another amendment to the spending bill of the Department of Defense. That amendment permitted the reenlistment of members even if they had used or been convicted of misdemeanor marijuana offenses while off-duty.

However, the VA has a history of pushing against any pro-marijuana amendments that come up for discussion, and the latest amendment filed by Rep. Clark is likely to get the same treatment. It would be enlightening to know what the different industry players like MustGrow Biologics Corp. and Marijuana Company of America Inc. (OTCQB: MCOA) would suggest as a way to get around this brick wall of VA resistance to marijuana policy reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – It’s Official, Illinois is 11th to Legalize Recreational Marijuana

As had been widely expected, Gov. J.B Pritzker yesterday (June 25) signed a bill legalizing recreational marijuana in Illinois. This makes the state the 11th to legalize marijuana fully, joining the likes of Colorado and California.

When this new law takes effect on Jan 1, 2020, adults 21 and older will be allowed to possess up to 30grams of marijuana and non-residents will be permitted to possess a maximum of 15grams.

The signing ceremony marked the fulfillment of a pledge Gov. Pritzker made when he was campaigning for office. He promised to see the swift legalization of recreational marijuana in order to bring needed revenue to the state, correct historical wrongs occasioned during the futile war on drugs and also shift scarce law enforcement resources to more serious crimes.

This law makes Illinois the first state to legalize recreational marijuana legislatively while creating a comprehensive framework for sales across the state. The other state (Vermont) which took this path just stopped at passing a law that created an agency to work out the details of full implementation.

Until legal sales start at the beginning of 2020, it will still be illegal to possess marijuana unless one is registered on the state’s medical marijuana program.

On the market side, the legalization law creates a first-of-its-kind mechanism through which people from impoverished communities will be helped to participate in the legal cannabis industry. This help will come in the form of fee waivers, low-interest loans and other forms of preferential treatment for “equity” applicants. A portion of all revenue generated from the marijuana industry will also be reinvested in impoverished communities in order to revive their economies.

Police departments have been jittery ever since the law was drafted, and their stiff opposition led to the dropping of a provision which would have seen residents allowed to grow up to five plants for recreational use. This opportunity now went to medical marijuana cardholders who weren’t initially allowed to grow marijuana for their own use.

Police departments are now worried that it will be hard for them to stay on top of people driving under the influence of marijuana since there isn’t reliable technology to test for impairment.

Meanwhile, hopes were high among advocates that New York and New Jersey would also legalize marijuana legislatively this year but the plans in those states fizzled out during spring. There is almost no doubt among cannabis industry analysts that the whole industry, including Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), has heaved a collective sigh of relief that the momentum of state-level legalization hasn’t stalled completely.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Mississippi Medical Cannabis Ballot Measure Close to Attaining Signature Target

Activists in Mississippi have revealed that they are about to reach the required number of voter signatures in order to see an initiative about medical marijuana included on the ballot in 2020.

Once the organizers submit that list of signatures, the Secretary of State will go through it and certify that each of the signatures belongs to a valid voter in the state. The organizers have emphasized that they will not stop once they reach the minimum number of signatures required. Instead, they will keep gathering more until the submission deadline in September is reached. The extra signatures will serve as an insurance policy just in case some of the signatures collected are deemed invalid. So far, about two-thirds of the required number of signatures have already been collected.

State law requires that if the petition is to be included on the ballot, it must be supported by at least 86,185 registered voters across the state. Additionally, the law also sets minimum numbers of signatures that have to be collected from each of the Congressional Districts in Mississippi.

The initiative for which signatures are being collected seeks to create a law under which patients suffering from debilitating conditions can consult their doctors and obtain a recommendation to use medical marijuana.

22 qualifying conditions, including PTSD, cancer, chronic pain and epilepsy have been suggested as conditions for which patients can use medical marijuana. Patients who get recommendations from their doctors and are registered by the state will be eligible to buy a maximum of 2.5 ounces of medical cannabis within a two-week window.

Currently, the state only allows a limited number of patient categories to use CBD oil to manage their health conditions. This oil has to be purchased from a few highly regulated suppliers whose products have been subjected to rigorous testing at the National Center for Natural Products Research.

The NCNPR is based at the University of Mississippi where the only federally approved manufacturing facility for research-grade cannabis is based.

If the medical marijuana initiative makes it onto the ballot and gets the approval of voters, the Department of Health will be responsible for establishing and regulating a more robust system through which patients can access medical marijuana.

The steps taken to get medical marijuana on the ballot in Mississippi follow the regional trend which has seen several states make marijuana law reforms. Texas has decriminalized marijuana possession and passed a bill to expand its medical cannabis program. Similarly, Alabama’s legislature recently passed a bill to legalize medical marijuana while Georgia also expanded its medical marijuana program.

According to analysts, the positive changes in this region of the U.S. could signal to industry players like MustGrow Biologics Corp. and Marijuana Company of America Inc. (OTCQB: MCOA) that the entire country may soon embrace marijuana policy reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – French Medical Marijuana Experiment Starting Soon After Enabling Law is Passed

On May 28 this year, the French Senate passed a bill paving the way for marijuana to start being used therapeutically in the country. The health ministry is yet to give its approval to this law, but once it does, an experiment lasting two years will be launched to analyze the effects of marijuana on pain relief.

Patient groups put the estimate of people who would be eligible to access marijuana for pain at about 300,000-1,000,000 people. A committee is evaluating the measures which have been designed to implement the medical cannabis experiment. This committee will release their findings on June 26.

The experiment is likely to get underway in a few weeks, but the biggest challenge which will be faced is how to set up a supply chain for the industry. Initially, medical cannabis will be imported from countries where it is legal and produced to internationally acceptable standards.

As medical cannabis is imported, locally licensed producers will be busy at work setting up cultivation facilities in greenhouses or highly controlled fields. The sunlight, humidity and temperature will all be closely monitored and controlled in this unconventional agricultural undertaking.

The growers selected will be required to meet the EU rules on how to grow medical cannabis whose quality is consistent.

Medical marijuana will not be a bonanza for all who wish to use it. Physicians will only prescribe it if a patient hasn’t benefited from all the available pain treatments in the country. Of special interest will be people suffering from cancer, multiple sclerosis, some forms of epilepsy and patients undergoing palliative care.

When addressing the French Senate at the beginning of the debate on the medical marijuana bill, Senator Esther Benbassa revealed that the list of conditions for which medical marijuana could be prescribed is likely to be expanded in future to include more ailments.

Some senators, especially those from the Republican Party, fear that the medical marijuana program is being used as a Trojan horse in a bid to legalize recreational marijuana. Advocates disagree and assert that medical marijuana cannot be abused for recreational purposes since the two uses require different forms of cannabis. For example, the advocates say that therapeutic-grade marijuana is low in THC, so recreational users cannot get the psychoactive effects which they require to address their needs.

Marijuana advocates welcomed the new bill and hope that the way will be opened for exploring other purposes for which marijuana can be used. These include wellness products like supplements, oils and cannabis-infused vitamins.

Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) welcome France into the fold of countries which are benefiting from the medicinal effects of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Canopy Rivers Invests in New Zealand Agri-Tech Company

Canopy Rivers, one of the largest growers and suppliers of medical marijuana in the world, has invested $1.5 million in BioLumic, an agri-tech company based in New Zealand. The funds are intended to help the agri-tech company to develop UV treatments which can boost the performance and yield of marijuana plants.

Warren Bebb, the CEO of BioLumic, said that he was glad that companies from around the world were starting to pick interest in what his company is doing. Bebb attributes this interest to the results which they have already obtained for other flowering plants, such as tomatoes, soybeans, lettuce and strawberries.

The New Zealand parliament recently passed a law to give terminally ill patients a legal defense to possess and use cannabis (an illegal substance). This amendment has paved the way for companies with interests in medical cannabis to position themselves to get a share of the global medical cannabis industry which is predicted to grow to an $80 billion industry within the coming five years.

BioLumic is excited to take a shot at making a difference in the life of someone suffering from a terminal illness. The UV treatments developed by the company have already shown that performance and yield can increase by up to 40 percent. Test crops have been grown in various countries, such as Spain, Britain and Mexico.

Dr. Wargent, one of the co-founders at BioLumic, says that his company is unique because of the shorter time they need to treat plants. For example, they need just a week or two to treat seedlings and only a few minutes to treat seeds.

Once the scientists have treated the seeds or seedlings, no other treatment is required for the rest of the life of that plant.

Wargent, a photobiologist, explains that he started out by testing his revolutionary technology on just a few plants that he left within his bedroom. Last year, he and Bebb opened a state-of-the-art UV research and development facility at Massey University.

While the founders weren’t sure which exact direction their company would take, they were in agreement that it should become a unicorn (a start-up which grows to be worth at least $1 billion).

The investment by Canopy Rivers and other entities has helped BioLumic to get its journey to unicorn status underway. The funding from Canopy Rivers will also go towards expanding the Artificial Intelligence program of BioLumic in addition to upgrading security at their trial facilities around the world.

Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) congratulate BioLumic upon landing such a major client in the cannabis industry and hope that their partnership results in a method to take medical marijuana production to a new level of efficiency.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – China Reaps from Cannabis Industry Boom

Look around your home and nearly half (or even more) of the products you see may have been made in China. Now China has jumped into the fray and it is bringing loads of CBD to the market in cosmetics, ingestible oil and other products.

This boom is largely centered in just two of China’s 34 provinces. These provinces are cultivating the plants even if Chinese law is very strict on psychotropic drugs, with death sentences routinely handed out to drug traffickers.

Hanma Investment Group is one of the first companies that secured a license to grow cannabis in Southern China in 2017. The CBD extracted is marketed outside China in balms, oils and sprays.

Hanma Investment Group has a subsidiary that is cultivating industrial hemp on more than 1,600 acres in Yunnan Province.

For thousands of years, hemp and marijuana were widely grown across China for making ropes, fabrics, paper and for medicinal purposes until the People’s Republic of China was founded and clamped down on the plant in 1949.

Hemp was also outlawed in 1985 when China signed the UN Convention on Psychotropic Substances despite hemp having just trace amounts of THC.

It is only recently (2010) that China softened its stance and allowed Yunnan province to resume growing hemp for textiles, especially for making uniforms for the People’s Liberation Army.

The exploding interest in CBD around the world has made Yunna Province to add oil extraction to the growing list of products for which hemp is grown. This booming industry has breathed new life into the economy of Yunna since farmers can earn much more from growing hemp ($300 from an acre) when compared to growing other crops, such as rapeseed or flax.

Yunna Province now has four companies that have, in total, opened more than 36,000 acres of land for hemp cultivation.

The other province which is reaping from hemp is Heilongjiang Province. Other provinces are catching on and plans are underway to license companies to start growing hemp in more regions of China.

The announcements that different companies have started growing hemp have caused such a stir on the stock exchanges that regulators were forced to intervene and stop trading in the shares of those companies.

Chinese companies are also aggressively staking their claim on the U.S. hemp landscape. For example, Hanma Investment Group has acquired a CBD extraction plant in Las Vegas, Nevada, and it has also set its eyes on Canada as well.

The 2018 Farm Act removed hemp from the list of controlled substances and it is now an agricultural commodity like any other within the U.S. The onus is now on U.S. companies to take full advantage of this legal reform so that China doesn’t muscle out local players in the CBD industry. Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) hope that U.S. companies are up to the challenge so that foreign firms don’t dominate the local CBD market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Trump Administration Opposed to Medical Cannabis for Military Veterans

The Department of Veterans Affairs has voiced its opposition to three bills that are intended to protect the VA benefits of veterans who use medical cannabis in states where it is legal, allow VA doctors to prescribe medical cannabis in states where it is legal and also expand research into the medical potential of cannabis.

The VA officials were speaking during a congressional hearing on Tuesday (April 30). For example, Keita Franklin (suicide prevention national director in the VA department) was of the view that the bill compelling the VA department to conduct research on the medical benefits and risks of cannabis was “too ambitious and risky” because a large number of human subjects would be involved.

Franklin also cited the guidance provided by the Drug Enforcement Administration to the effect that VA medical personnel aren’t allowed to prescribe medical marijuana in states where medical marijuana is legal.

Furthermore, the VA officials explained that they are also opposed to the bill which seeks to protect the VA benefits of veterans who consume medical cannabis in states where it is legal because the department already has a policy to that effect.

However, the sponsor of the bill insisted that the policy referred to isn’t sufficient since another administration can decide to reverse it. The best option is to write those protections into law, the lawmakers argued.

Several military veterans’ advocacy groups were also represented and expressed strong support for all the bills. The groups included Disabled American Veterans, Veterans of Foreign Wars and Iraq and Afghanistan Veterans of America.

The strongest support among these advocacy groups was directed towards the bill seeking for more research into the therapeutic effects of marijuana.

The Veterans of Foreign Wars was however concerned that the VA wouldn’t be able to avail medical cannabis at its health facilities even if a policy shift occurred to permit doctors to prescribe medical marijuana. For this reason, the group wasn’t in support of the bill that intends to allow VA doctors to prescribe cannabis.

Some lawmakers were frustrated by the continuous stonewalling exhibited by the VA each time marijuana is up for discussion. The lawmakers suggested that it may be necessary to push for cannabis rescheduling since any bill that is passed will need the approval of the DEA, and the same response (rejection) will be given.

Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) can’t wait for the day when the debate on medical marijuana will focus on facts and the needs of the intended beneficiaries rather than on politics.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – American Cannabis Sales Expected to Double on 4/20

For the uninitiated, 4/20 in the marijuana industry can be equated to Fourth of July. The exact origin of that “holiday” isn’t known, but there is speculation that the day is named after the time of the day (4:20 p.m.) when a group of students would meet outside their high school in the 1970s to hunt for some legendary cannabis plants that had been abandoned. According to that myth, those students never found that marijuana crop, so they doggedly kept up their search.

On 4/20, sales of marijuana are expected to, at the very least, double at all retail facilities in the U.S. states where recreational cannabis is legal.

This projection is drawn from the data collected by Headset Inc. The statistics show that historically, 4/20 has been the busiest day for pot sellers. This is especially true when that date falls on a Friday.

According to Headset Inc., 4/20 last year saw a 111 percent jump in sales when the sales on that day were compared to the cannabis sales on four Fridays before that day and another four after the “holiday.” The data analyzed was taken from Washington State, Nevada, Colorado and California.

In comparison, beer sales registered a modest jump in the two weeks that included July 4. Only a 33 percent rise in sales was discovered when the number crunchers did the math. This shows that cannabis “holidays” draw a more enthusiastic weed buyer response when compared to the way beer consumers behave on July 4.

Another way to see it would be that the trajectory of cannabis sales is on a sharp rise while beer sales reached their peak long ago, so holidays cannot trigger major movements in the market.

As already indicated, last year’s 4/20 fell on a Friday, a day when cannabis consumers seem to visit retail outlets more. This year’s 4/20 will be on Saturday, so that brings even better news to recreational cannabis retailers since the “eve” of 4/20 will be a magnet to buyers and the “holiday” itself will also inspire cannabis consumers to spend on weed. Chances are therefore high that marijuana sales will be record-breaking during that long Easter weekend.

The cannabis crowd across the border in Canada will not enjoy the day as much as their American counterparts will. This is because any added demand for recreational cannabis in Canada will be dampened by the persistent supply shortages that have refused to go away since weed was legalized on October 17, 2018.

Queues will be longer on that day, especially in places like Toronto where retail facilities are limited. And unfortunately, not all who line up will leave a retail store with their first-choice cannabis product. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America (OTCQB: MCOA) look forward to the day when there will be no more cannabis shortages in Canada so that the people there can access all the products that they want.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Student-Organized Event Discusses Cannabis on Sidelines of Michigan Hash Bash

Every year, a Hash Bash festival is held in Ann Arbor as a day of having fun and entertainment. This year, law students at Michigan Law School worked with the organizers of the Hash Bash festival to host an event at the law school to discuss marijuana legalization politics.

This event was held yesterday (Sunday, April 7) while the Hash Bash took place on Saturday. The organizers of the event at Michigan Law School wanted to educate members of the public about issues related to marijuana. Several panelists made presentations on various issues.

Ari Goldstein, a law student who was one of the organizers, remarked that marijuana legalization brings entrepreneurial opportunities that haven’t been seen since the Great Depression, so every effort must be taken to prepare people to seize those opportunities.

Kevin Boehnke, who is a research fellow at Michigan University’s Department of Anesthesiology, revealed during his presentation that several patient studies point to the fact that more patients are opting for medical marijuana to manage pain instead of using prescription opioids.

The shift is due to the better symptom relief experienced by patients, and the concerns about the documented side effects of prescription opioids.

Another panelist, Gus Rosania (a professor of pharmacological sciences) handled the topic of natural vs. synthetic cannabis ingredients. Rosania dispelled the misconception that synthetic cannabis is different from natural cannabis.

He revealed that at the basic level, synthetic marijuana is chemically identical to natural marijuana, so it is hard to tell the two apart. He added that it was only because different ingredients could be isolated and made in a lab that it was possible to identify the different cannabinoids in marijuana.

Andrew Brisbo, the head of Michigan’s Bureau of Marijuana Regulation, was also in attendance to talk about the ramifications of the legalization of recreational cannabis in the state. He revealed that he had a huge task on his desk to put together a program for recreational cannabis implementation in just a year from the time the law was passed.

Brisbo intimated that one way that he was using to get everything done correctly is by engaging different stakeholders in order to tap their perspectives when putting together an implementation plan.

Many people in the audience expressed their frustration about how hard it was for them to get a medical cannabis prescription from their doctors. Brisbo expressed sympathy for their plight and revealed that it wasn’t easy to change attitudes about cannabis after such a long time of prohibition. He added that efforts were underway to give physicians more information about medical cannabis so that they can gradually warm up to prescribing it to their patients who qualify for such treatment.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America, Inc. (OTCQB: MCOA) welcome such engagements between regulators, patients, professors and other stakeholders since such interactions can result in better cannabis industry policies.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com